No association of FcγRIIa, FcγRIIIa and FcγRIIIb polymorphisms with MS

被引:8
作者
Breij, ECW
van der Pol, WL
van Winsen, L
Jansen, MD
Dijkstra, CD
van de Winkel, JGJ
Uitdehaag, BMJ
机构
[1] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol, NL-1081 BT Amsterdam, Netherlands
[2] Univ Utrecht, Med Ctr, Dept Immunol, NL-3584 EA Utrecht, Netherlands
[3] Univ Utrecht, Med Ctr, Dept Neurol, NL-3584 CX Utrecht, Netherlands
[4] Vrije Univ Amsterdam, Med Ctr, Dept Neurol, NL-1081 HV Amsterdam, Netherlands
[5] Genmab, Utrecht, Netherlands
关键词
multiple sclerosis; Fc gamma receptors; polymorphisms;
D O I
10.1016/S0165-5728(03)00207-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Anti-myelin IgGs occur in the cerebrospinal fluid (CSF) and serum of multiple sclerosis (MS) patients, and can induce inflammatory effector functions in leukocytes by crosslinking IgG receptors (FcgammaR). The efficiency of FcgammaR-mediated inflammatory processes is affected by functional polymorphisms of three Fcgamma receptors (FcgammaRIIa, FcgammaRIIIa, FcgammaRIIIb). The relevance of FcgammaR polymorphisms in MS was evaluated by studying the distribution of FcgammaRIIa, FcgammaRIIIa and FcgammaRIIIb genotypes in 432 MS patients and 515 healthy controls. No significant differences were found between MS patients and controls, or between subgroups of patients. We conclude that Fcgamma receptor polymorphisms influence neither susceptibility nor clinical disease course of MS. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:210 / 215
页数:6
相关论文
共 36 条
  • [1] BREDIUS RGM, 1994, IMMUNOLOGY, V83, P624
  • [2] Heparin-induced thrombocytopenia:: New insights into the impact of the FcγRIIa-R-H131 polymorphism
    Carlsson, LE
    Santoso, S
    Baurichter, G
    Kroll, H
    Papenberg, S
    Eichler, P
    Westerdaal, NAC
    Kiefel, V
    van de Winkel, JGJ
    Greinacher, A
    [J]. BLOOD, 1998, 92 (05) : 1526 - 1531
  • [3] Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis
    Cepok, S
    Jacobsen, M
    Schock, S
    Omer, B
    Jaekel, S
    Böddeker, I
    Oertel, WH
    Sommer, N
    Hemmer, B
    [J]. BRAIN, 2001, 124 : 2169 - 2176
  • [4] B cells and antibodies in CNS demyelinating disease
    Cross, AH
    Trotter, JL
    Lyons, JA
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2001, 112 (1-2) : 1 - 14
  • [5] NEUTROPHIL FC-GAMMA-RIIIB DEFICIENCY, NATURE, AND CLINICAL CONSEQUENCES - A STUDY OF 21 INDIVIDUALS FROM 14 FAMILIES
    DEHAAS, M
    KLEIJER, M
    VANZWIETEN, R
    ROOS, D
    VONDEMBORNE, AEGK
    [J]. BLOOD, 1995, 86 (06) : 2403 - 2413
  • [6] Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients
    Duits, AJ
    Bootsma, H
    Derksen, RHWM
    Spronk, PE
    Kater, L
    Kallenberg, CGM
    Capel, PJA
    Westerdaal, NAC
    Spierenburg, GT
    GmeligMeyling, FHJ
    vandeWinkel, JGJ
    [J]. ARTHRITIS AND RHEUMATISM, 1995, 38 (12): : 1832 - 1836
  • [7] Genetics of multiple sclerosis
    Ebers, GC
    Dyment, DA
    [J]. SEMINARS IN NEUROLOGY, 1998, 18 (03) : 295 - 299
  • [8] The immunopathogenesis of multiple sclerosis and Guillain-Barre syndrome
    Giovannoni, G
    Hartung, HP
    [J]. CURRENT OPINION IN NEUROLOGY, 1996, 9 (03) : 165 - 177
  • [9] HUIZINGA TWJ, 1990, BLOOD, V75, P213
  • [10] Intrathecal IgG synthesis:: marker of progression in multiple sclerosis patients
    Izquierdo, G
    Angulo, S
    Garcia-Moreno, JM
    Gamero, MA
    Navarro, G
    Gata, JM
    Ruiz-Peña, JL
    Páramo, MD
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 2002, 105 (03): : 158 - 163